Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2019 Filed Nov 7, 2019 22:00 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,820 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-19-032218 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,880 Underlying: Common Stock · 1,820 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 22:00 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
SaleCommon Stock | 1,820 | $109.34 | $198,998.80 |
DisclosureSEC source: 0001127602-19-032218 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.91 to $109.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 22:00 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 1,820 | $39.87 | $72,563.40 |
DisclosureSEC source: 0001127602-19-032218 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 14:12 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031223 · form4.xml · derivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600 shares Expires 2022-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 14:12 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 177 | $97.76 | $17,303.52 |
DisclosureSEC source: 0001127602-19-031223 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,497 Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 14:12 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031223 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 16:05 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 15 | $91.34 | $1,370.10 |
DisclosureSEC source: 0001127602-19-029588 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,230 Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 19:05 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantCommon Stock | 18 | $91.34 | $1,644.12 |
DisclosureSEC source: 0001127602-19-029663 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,558 Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 18:56 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantCommon Stock | 51 | $91.34 | $4,658.34 |
DisclosureSEC source: 0001127602-19-029662 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181 Read SEC document |
| September 23, 2019 Filed Sep 24, 2019 19:13 UTC |
Schwarzentraub Barbara JDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,515 | $0.00 Strike: $100.52 | $0.00 |
DisclosureSEC source: 0001127602-19-029003 · form4.xml · derivative · entry 2 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515 Underlying: Common Stock · 1,515 shares Expires 2029-09-23 F2 · derivative.exercise_date: The incentive stock options ("Options") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan with the Options generally vesting on September 23, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting Read SEC document |
| September 23, 2019 Filed Sep 24, 2019 19:13 UTC |
Schwarzentraub Barbara JDirector
|
GrantRsus (restricted Stock Units) · Derivative | 895 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-029003 · form4.xml · derivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 895 Underlying: Common Stock · 895 shares Expires 2029-09-23 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting on September 23, 2020 subject to the director's completion of the term of service through the next annual shareholder meeting. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 21:05 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 500 | $101.76 | $50,880.00 |
DisclosureSEC source: 0001127602-19-027522 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130 Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 19:10 UTC |
Berge Terence MVP-Corporate Controller
|
SaleCommon Stock | 8,300 | $95.02 | $788,674.30 |
DisclosureSEC source: 0001127602-19-026378 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,908 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95 to $95.18. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 15:52 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-19-026483 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 Underlying: Common Stock · 2,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 15:52 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
SaleCommon Stock | 2,000 | $95.31 | $190,620.00 |
DisclosureSEC source: 0001127602-19-026483 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 Read SEC document |
| August 09, 2019 Filed Aug 13, 2019 15:52 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 2,000 | $39.87 | $79,740.00 |
DisclosureSEC source: 0001127602-19-026483 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 18:38 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 300 | $94.94 | $28,482.00 |
DisclosureSEC source: 0001127602-19-026377 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665 Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 18:38 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 153 | $94.91 | $14,521.23 |
DisclosureSEC source: 0001127602-19-026377 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,965 Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:17 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,560 | $0.00 Strike: $44.90 | $0.00 |
DisclosureSEC source: 0001127602-19-026235 · form4.xml · derivative · entry 7 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,560 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:17 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-19-026235 · form4.xml · derivative · entry 6 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,100 Underlying: Common Stock · 12,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:17 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
SaleCommon Stock | 2,909 | $92.10 | $267,918.90 |
DisclosureSEC source: 0001127602-19-026235 · form4.xml · nonDerivative · entry 5 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,215 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92 to $92.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:17 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 1,157 | $92.94 | $107,531.58 |
DisclosureSEC source: 0001127602-19-026235 · form4.xml · nonDerivative · entry 4 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,124 Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:17 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 1,560 | $44.90 | $70,044.00 |
DisclosureSEC source: 0001127602-19-026235 · form4.xml · nonDerivative · entry 3 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:17 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 8,598 | $92.01 | $791,101.98 |
DisclosureSEC source: 0001127602-19-026235 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,721 Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:17 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 12,000 | $39.87 | $478,440.00 |
DisclosureSEC source: 0001127602-19-026235 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 14,400 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · derivative · entry 9 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Underlying: Common Stock · 14,400 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 6,500 | $0.00 Strike: $44.90 | $0.00 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · derivative · entry 8 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,500 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 10,000 | $0.00 Strike: $32.93 | $0.00 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · derivative · entry 7 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Tax withholdingCommon Stock | 11,108 | $92.94 | $1,032,377.52 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · nonDerivative · entry 6 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,208 Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 14,400 | $51.30 | $738,720.00 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · nonDerivative · entry 5 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Tax withholdingCommon Stock | 4,786 | $92.94 | $444,810.84 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · nonDerivative · entry 4 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,916 Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 6,500 | $44.90 | $291,850.00 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Tax withholdingCommon Stock | 6,706 | $92.94 | $623,255.64 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,202 Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 21:13 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 10,000 | $32.93 | $329,300.00 |
DisclosureSEC source: 0001127602-19-026234 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,549 | $0.00 Strike: $69.03 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 11 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,549 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 3,669 | $0.00 Strike: $51.90 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 10 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,669 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,396 | $0.00 Strike: $41.06 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 9 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,396 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
SaleCommon Stock | 2,549 | $91.17 | $232,392.33 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 6 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Exercise / conversionCommon Stock | 2,549 | $69.03 | $175,957.47 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 5 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
SaleCommon Stock | 3,669 | $91.04 | $334,025.76 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 4 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.19. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Exercise / conversionCommon Stock | 3,669 | $51.90 | $190,421.10 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 3 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
SaleCommon Stock | 5,396 | $91.10 | $491,575.60 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 2 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.00 to $91.68. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Exercise / conversionCommon Stock | 5,396 | $41.06 | $221,559.76 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · nonDerivative · entry 1 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:00 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 2,000 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-19-026176 · form4.xml · derivative · entry 3 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:00 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Tax withholdingCommon Stock | 1,547 | $92.38 | $142,911.86 |
DisclosureSEC source: 0001127602-19-026176 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,118 Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:00 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 2,000 | $51.30 | $102,600.00 |
DisclosureSEC source: 0001127602-19-026176 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Disposition to issuerRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 8 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F6 · shares: The RSUs expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service. F7 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| August 01, 2019 Filed Aug 6, 2019 15:42 UTC |
Kuyper DirkDirector
|
Disposition to issuerOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-026120 · form4.xml · derivative · entry 7 Kuyper Dirk · CIK 0001404850 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F4 · shares: The stock options expired without vesting as a consequence of Mr. Kuyper's resignation from the Board prior to the completion of the 2019 term of service. F5 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:54 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
GrantCommon Stock | 12 | $81.29 | $975.48 |
DisclosureSEC source: 0001127602-19-023621 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 630 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 14:57 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 55 | $81.29 | $4,470.95 |
DisclosureSEC source: 0001127602-19-023349 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,319 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.